1,494
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Topical Beta-Blockers and Cardiovascular Mortality: Systematic Review and Meta-Analysis with Data from the EPIC-Norfolk Cohort Study

, , , , , , , & show all
Pages 277-284 | Received 06 Aug 2015, Accepted 20 Mar 2016, Published online: 23 Aug 2016

References

  • National Institute for Health and Care Excellence (NICE). CG85: Glaucoma: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. London, UK: NICE, 2009.
  • Lee AJ, Wang JJ, Kifley A, et al. Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study. Ophthalmology 2006;113:1069–1076.
  • Wu SY, Nemesure B, Hennis A, et al. Open-angle glaucoma and mortality: the Barbados Eye Studies. Arch Ophthalmol 2008;126:365–370.
  • Nieminen T, Lehtimaki T, Maenpaa J, et al. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand J Clin Lab Invest 2007;67:237–245.
  • Yamamoto T, Kitazawa Y, Noma A, et al. The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients. J Glaucoma 1996;5:252–257.
  • Mitchell P, Wang JJ, Cumming RG, et al. Long-term topical timolol and blood lipids: the Blue Mountains Eye Study. J Glaucoma 2000;9:174–178.
  • Freedman SF, Freedman NJ, Shields MB, et al. Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol 1993;116:600–611.
  • Stewart WC, Garrison PM. Beta-blocker-induced complications and the patient with glaucoma. Newer treatments to help reduce systemic adverse events. Arch Int Med 1998;158:221–226.
  • Muskens RP, Wolfs RC, Witteman JC, et al. Topical beta-blockers and mortality. Ophthalmology 2008;115:2037–2043.
  • Connor AJ, Fraser SG. Glaucoma prescribing trends in England 2000 to 2012. Eye 2014;28:863–869.
  • Perry CM, McGavin JK, Culy CR, et al. Latanoprost: an update of its use in glaucoma and ocular hypertension. Drugs Aging 2003;20:597–630.
  • Day N, Oakes S, Luben R, et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999;80(Suppl. 1):95–103.
  • Shields B. Text book of glaucoma, 6th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2010.
  • NEHEM. National Eye Health Epidemiological Model. 2014. Available from: www.eyehealthmodel.org
  • Connor AJ, Fraser SG. Glaucoma prescribing trends in England 2000 to 2012. Eye (London, England) 2014;28:863–869.
  • Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Int Med 2001;134:550–560.
  • Quint JK, Herrett E, Bhaskaran K, et al. Effect of beta blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records. BMJ 2013;347:f6650.
  • Lee DS, Markwardt S, McAvay GJ, et al. Effect of beta-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary disease. Medical Care 2014;52(Suppl. 3):S45–51.
  • Al-Gobari M, El Khatib C, Pillon F, et al. beta-Blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders 2013;13:52.
  • Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349–361.
  • Gundersen T, Kjekshus J, Stokke O, et al. Timolol maleate and HDL cholesterol after myocardial infarction. Eur Heart J 1985;6:840–844.
  • Boekholdt SM, Peters RJ, Day NE, et al. Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study. Am J Med 2004;117:390–397.
  • Leske MC, Wu SY, Nemesure B, et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol 2002;120:954–959.
  • Dielemans I, Vingerling JR, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102:54–60.
  • Mitchell P, Smith W, Chey T, et al. Open-angle glaucoma and diabetes: the Blue Mountains eye study, Australia. Ophthalmology 1997;104:712–718.
  • Tielsch JM, Katz J, Quigley HA, et al. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995;102:48–53.
  • Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol 1991;134:1102–1110.
  • Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology 1996;103:1661–1669.